M
MBX
MBX Biosciences Inc
31.00
-1.86-5.66%After Hours: 31.60 +0.60 +1.94%18:00 04/10 EDT
OPEN/PREV CLOSE33.24/32.86
TODAY RANGE30.76-33.80
VOL284.26K
MARKET CAP1.47B
52 WEEK RANGE4.807-44.89
AVG VOL (3M)629.88K
% TURNOVER0.60%
TURNOVER--
P/E (TTM)-13.0121
% RANGE9.25%
EPS(TTM)-2.3824
P/E(FORWARD)-10.6713
P/B3.772
BVPS8.22
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.11B
SHARES OUTSTANDING47.51M
NEXT EARNINGS05/11-05/15
FREE FLOAT35.90M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·04/03 15:23
MBX Biosciences (MBX) Is Up 16.6% After Analyst Initiation And Leadership Award News Has The Bull Case Changed?
TipRanks·04/02 08:45
MBX Biosciences, Inc. (MBX) Receives a Buy from Barclays
TipRanks·03/31 11:46
MBX Biosciences initiated with an Outperform at LifeSci Capital
Simply Wall St·03/30 04:19
Assessing MBX Biosciences (MBX) Valuation After CEO Share Purchase And Phase 3 Hypoparathyroidism Plans
Simply Wall St·03/25 11:07
MBX Biosciences (MBX) Is Down 6.5% After Wider Losses And New Shelf Filings Has The Bull Case Changed?
TipRanks·03/23 12:06
Options Volatility and Implied Earnings Moves Today, March 23, 2026
NASDAQ·03/18 18:07
Wednesday 3/18 Insider Buying Report: MDRR, MBX
TipRanks·03/17 02:09
MBX Biosciences Chief Makes Bold Insider Move With Major Stock Buy
Simply Wall St·03/16 13:11
A Look At MBX Biosciences (MBX) Valuation After Recent Share Price Pullback
Reuters·03/16 12:03
MBX Biosciences CEO P. Kent Hawryluk acquires USD 526,000 in common shares
TipRanks·03/12 22:05
Mizuho Securities Sticks to Their Buy Rating for MBX Biosciences, Inc. (MBX)